The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01 E by Ali, MS, Stockdale, L, Sagara, I, Zongo, I, Yerbanga, RS, Mahamar, A, Nikièma, F, Tapily, A, Sompougdou, F, Diarra, M, Bellamy, D, Provstgaard-Morys, S, Zoungrana, C, Issiaka, D, Haro, A, Sanogo, K, Sienou, AA, Kaya, M, Traore, S, Dicko, OM, Kone, Y, Yalcouye, H, Thera, I, Diarra, K

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial by Datoo, MS, Dicko, A, Tinto, H, Ouédraogo, J-B, Hamaluba, M, Olotu, A, Beaumont, E, Ramos Lopez, F, Natama, HM, Weston, S, Chemba, M, Compaore, YD, Issiaka, D, Salou, D, Some, AM, Omenda, S, Lawrie, A, Bejon, P, Rao, H, Chandramohan, D, Roberts, R, Bharati, S, Stockdale, L, Gairola, S, Greenwood, BM, Ewer, KJ, Bradley, J, Kulkarni, PS, Shaligram, U, Hill, AVS